Published in Hypertens Pregnancy on January 01, 2005
Severe preeclampsia-related changes in gene expression at the maternal-fetal interface include sialic acid-binding immunoglobulin-like lectin-6 and pappalysin-2. Endocrinology (2008) 1.47
Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis. BMC Pregnancy Childbirth (2008) 0.96
Human placental microRNAs and preeclampsia. Biol Reprod (2013) 0.94
Identification of the primary outcomes that result from deficient spiral arterial modification in pregnant mice. Pregnancy Hypertens (2011) 0.92
Mid-trimester maternal serum HCG and alpha fetal protein levels: clinical significance and prediction of adverse pregnancy outcome. Int J Endocrinol Metab (2013) 0.91
Novel Electrocardiographic Patterns for the Prediction of Hypertensive Disorders of Pregnancy--From Pathophysiology to Practical Implications. Int J Mol Sci (2015) 0.82
Maternal mortality in the UK and the need for obstetric physicians. BMJ (2011) 2.51
The fetal cardiovascular response to antenatal steroids in severe early-onset intrauterine growth restriction. Am J Obstet Gynecol (2004) 2.13
The pre-eclampsia community guideline (PRECOG): how to screen for and detect onset of pre-eclampsia in the community. BMJ (2005) 2.08
Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med (2006) 1.83
Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol (2006) 1.81
Altered gene expression and methylation of the human chromosome 11 imprinted region in small for gestational age (SGA) placentae. Dev Biol (2008) 1.51
A puzzling intrauterine death: non-compaction of the fetal ventricular myocardium presenting with reversed end-diastolic flow velocity in the umbilical arteries. J Obstet Gynaecol Can (2005) 1.51
Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med (2004) 1.39
Oxytocin requirements at elective cesarean delivery: a dose-finding study. Obstet Gynecol (2004) 1.15
Cell specific patterns of methylation in the human placenta. Epigenetics (2011) 1.12
Taurocholate induces changes in rat cardiomyocyte contraction and calcium dynamics. Clin Sci (Lond) (2002) 1.08
Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab (2007) 1.05
The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol (2010) 1.04
Prolongation of the atrioventricular conduction in fetuses exposed to maternal anti-Ro/SSA and anti-La/SSB antibodies did not predict progressive heart block. A prospective observational study on the effects of maternal antibodies on 165 fetuses. J Am Coll Cardiol (2011) 1.03
Causes and mechanisms of intrauterine hypoxia and its impact on the fetal cardiovascular system: a review. Int J Pediatr (2010) 1.02
Minimum oxytocin dose requirement after cesarean delivery for labor arrest. Obstet Gynecol (2006) 1.02
Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases. Am J Med Genet A (2008) 0.99
Reduced cystathionine γ-lyase and increased miR-21 expression are associated with increased vascular resistance in growth-restricted pregnancies: hydrogen sulfide as a placental vasodilator. Am J Pathol (2013) 0.98
Prediction of adverse pregnancy outcomes by combinations of first and second trimester biochemistry markers used in the routine prenatal screening of Down syndrome. Prenat Diagn (2010) 0.96
Peroxisome proliferator-activated receptor-γ as a potential therapeutic target in the treatment of preeclampsia. Hypertension (2011) 0.95
Fusion assays and models for the trophoblast. Methods Mol Biol (2008) 0.94
Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Am J Obstet Gynecol (2003) 0.94
The management of postpartum hypertension. BJOG (2002) 0.94
Expectant management compared with elective delivery at 37 weeks for gastroschisis. Obstet Gynecol (2013) 0.93
Pregnancy and contraception in heart disease and pulmonary arterial hypertension. J Fam Plann Reprod Health Care (2006) 0.92
Translational analysis of mouse and human placental protein and mRNA reveals distinct molecular pathologies in human preeclampsia. Mol Cell Proteomics (2011) 0.92
Oxytocin pretreatment decreases oxytocin-induced myometrial contractions in pregnant rats in a concentration-dependent but not time-dependent manner. Reprod Sci (2009) 0.92
Assessment of the evolution of normal fetal diastolic function during mid and late gestation by spectral Doppler tissue echocardiography. J Am Soc Echocardiogr (2006) 0.92
Evidence implicating peroxisome proliferator-activated receptor-γ in the pathogenesis of preeclampsia. Hypertension (2011) 0.91
Male sex bias in placental dysfunction. Am J Med Genet A (2012) 0.90
A randomized controlled trial of a bedside partogram in the active management of primiparous labour. J Obstet Gynaecol Can (2007) 0.88
WNT2 promoter methylation in human placenta is associated with low birthweight percentile in the neonate. Epigenetics (2011) 0.87
Perinatal and neurodevelopmental outcome with isolated fetal ventriculomegaly: a systematic review. J Matern Fetal Neonatal Med (2005) 0.87
Glial cell missing-1 mediates over-expression of tissue inhibitor of metalloproteinase-4 in severe pre-eclamptic placental villi. Hum Reprod (2011) 0.86
Postpartum assessment of the renin angiotensin system in women with previous severe, early-onset preeclampsia. J Clin Endocrinol Metab (2011) 0.86
Medical deaths in pregnancy. Clin Med (2008) 0.85
Oxytocin pretreatment of pregnant rat myometrium reduces the efficacy of oxytocin but not of ergonovine maleate or prostaglandin F 2 alpha. Reprod Sci (2010) 0.85
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev (2010) 0.85
Oxytocin pretreatment attenuates oxytocin-induced contractions in human myometrium in vitro. Anesthesiology (2013) 0.83
Antithrombotic therapy for improving maternal or infant health outcomes in women considered at risk of placental dysfunction. Cochrane Database Syst Rev (2013) 0.82
Elective non-removal of the placenta and prophylactic uterine artery embolization postpartum as a diagnostic imaging approach for the management of placenta percreta: a case report. J Obstet Gynaecol Can (2004) 0.82
Complex umbilical cord entanglement. J Matern Fetal Neonatal Med (2012) 0.81
Randomized controlled trial of rectal misoprostol versus oxytocin in third stage management. J Obstet Gynaecol Can (2002) 0.81
Angiogenic response of placental villi to heparin. Obstet Gynecol (2011) 0.80
Rounded intraplacental haematomas due to decidual vasculopathy have a distinctive morphology. J Clin Pathol (2011) 0.80
Severe hyponatraemia and pre-eclampsia. BJOG (2004) 0.79
Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia. BJOG (2005) 0.79
Non-invasive hemodynamic assessment of non-pregnant, healthy pregnant and preeclamptic women using bioreactance. [corrected]. Rev Bras Anestesiol (2010) 0.79
Complications of exteriorized compared with in situ uterine repair at cesarean delivery under spinal anesthesia: a randomized controlled trial. Obstet Gynecol (2007) 0.78
Third-trimester stillbirths: correlative neuropathology and placental pathology. Pediatr Dev Pathol (2011) 0.78
The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial. Thromb Haemost (2007) 0.78
The management of VBAC at term: a survey of Canadian obstetricians. J Obstet Gynaecol Can (2003) 0.78
The Effect of Extracellular Calcium on Oxytocin-Induced Contractility in Naive and Oxytocin-Pretreated Human Myometrium In Vitro. Anesth Analg (2016) 0.78
Prenatal diagnosis, clinical outcomes, and associated pathology in pregnancies complicated by massive subchorionic thrombohematoma (Breus' mole). Prenat Diagn (2013) 0.77
Angiogenic factor abnormalities and fetal demise in a twin pregnancy. Nat Rev Nephrol (2009) 0.77
Preeclampsia with abnormal liver function tests is associated with cholestasis in a subgroup of cases. Hypertens Pregnancy (2004) 0.76
Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia. BJOG (2002) 0.76
Treatment options in fetomaternal hemorrhage: four case studies. J Obstet Gynaecol Can (2004) 0.76
Asthma in pregnancy: Attacks seem rare in labour. BMJ (2007) 0.75
Comparative efficacy of uterotonic agents: in vitro contractions in isolated myometrial strips of labouring and non-labouring women. Can J Anaesth (2014) 0.75
Contractile efficacy of various prostaglandins in pregnant rat myometrium pretreated with oxytocin. Reprod Sci (2012) 0.75
Misoprostol associated refractile material in fetal and placental tissues after medical termination of pregnancy. Am J Surg Pathol (2007) 0.75
Nonpresenting Dichorionic Twins and Placental Vascular Malperfusion. Obstet Gynecol (2017) 0.75
The Contractile Effects of Oxytocin, Ergonovine, and Carboprost and Their Combinations: an In Vitro Study on Human Myometrial Strips. Anesth Analg (2015) 0.75
Altered placental development in pregnancies resulting in sudden infant death syndrome (SIDS). Early Hum Dev (2012) 0.75
Basal plate plaque: a novel organising placental thrombotic process. J Clin Pathol (2011) 0.75
Obstretic medicine: interdisciplinary care for pregnancy and for women wishing to conceive. Rev Med Chil (2006) 0.75
Spontaneous uterine rupture. J Obstet Gynaecol Can (2009) 0.75